PETV
PetVivo Holdings, Inc.
$0.8000
0.00%
No data for this timeframe.
Vol
Insider Activity6B / 0S
Insider Net $$115.7K
SEC Reports1
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. NV·CIK 0001512922·Prev Close $0.8000
Recent Activity
Jun 9, 2026
Insider
A.L. Sarroff Fund, LLC bought 187,500 shares
10%+ Owner
Jun 9, 2026
Insider
A.L. Sarroff Fund, LLC bought 187,500 shares
10%+ Owner
May 28, 2026
Insider
A.L. Sarroff Fund, LLC gifted 200,000 shares
10%+ Owner
Mar 4, 2026
SEC
PetVivo Holdings, Inc. filed an 8-K to disclose that its management intends to present an investor presentation at upcom
8-K — Impact 3/10
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2021 | ThinkEquity | INITIATE | Buy |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | A.L. Sarroff | BUY | $0.00 |
| Jun 9, 2026 | A.L. Sarroff | BUY | $0.00 |
| May 28, 2026 | A.L. Sarroff | G | $0.00 |
| May 22, 2026 | A.L. Sarroff | BUY | $100.0K |
| May 15, 2026 | Lai John | A | $47.8K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
8 unique insiders with 18 transactions. Net insider value: $115.7K ($115.7K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 187,500 | — | — |
| Jun 9, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 187,500 | — | — |
| May 28, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | GIFT | 200,000 | — | — |
| May 22, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 250,000 | $0.4000 | $100.0K |
| May 15, 2026 | Lai John | Chief Executive Officer | AWARD | 66,421 | $0.7200 | $47.8K |
| May 15, 2026 | LOWENTHAL GARRY N | Chief Financial Officer | AWARD | 66,421 | $0.7200 | $47.8K |
| Apr 15, 2026 | Rudelius Robert James | Director | AWARD | 50,000 | $0.4000 | $20.0K |
| Mar 23, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 23,033 | $0.6800 | $15.7K |
| Mar 13, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 1,250,000 | — | — |
| Mar 13, 2026 | A.L. Sarroff Fund, LLC | 10%+ Owner | BUY | 1,250,000 | — | — |
| Mar 9, 2026 | LOWENTHAL GARRY N | Chief Financial Officer | AWARD | 71,993 | $0.6900 | $49.7K |
| Mar 9, 2026 | Lai John | Chief Executive Officer | AWARD | 72,282 | $0.6900 | $49.9K |
| Mar 9, 2026 | Costantino Robert J | Director | AWARD | 35,000 | $0.7400 | $25.9K |
| Mar 9, 2026 | Jasper Joseph William | Director | AWARD | 35,000 | $0.7400 | $25.9K |
| Mar 9, 2026 | Levitan Diane M | Director | AWARD | 15,000 | $0.7400 | $11.1K |
| Mar 9, 2026 | Ruben Joshua David | Director | AWARD | 7,500 | $0.7400 | $5.5K |
| Mar 9, 2026 | Rudelius Robert James | Director | AWARD | 35,000 | $0.7400 | $25.9K |
| Jan 2, 2026 | Ruben Joshua David | Director | AWARD | 46,332 | $0.7400 | $34.3K |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 3.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Oct 2021): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Oct 12, 2021 | ThinkEquity | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2022 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2022 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.